EWTX
Edgewise Therapeutics, Inc. · Healthcare
President and CEO Kevin Koch sold $60K of Edgewise Therapeutics, Inc.
Sold$59,604
$18.91Price
3,152Shares
−1%Stake
What EWTX did after the filing
- The stock from Fri, May 3 close, $19.52
- −11.0%
- S&P 500, same days
- +7.0%
Measured over 30 trading days, to the Jun 17 close.
Traded Thu, May 2. Filed Fri, May 3, 2:26 PM ET, during the session. Returns use the May 3 close and the Jun 17 close. Not investment advice.